News

Nurses face 'impossible' HPV workload

04-Aug-08

Nurses in practices and schools face an 'impossible' workload after the DoH announced plans to vaccinate 300,000 teenagers against HPV starting next month.

The work will be required after the DoH announced a catch-up campaign for 17- to 18-year-old girls in England. This is in addition to the routine vaccination of girls aged 12 to 13, which also begins next month, and a further catch-up programme for girls up to the age of 18 that begins in September 2009.

The extra year of girls being offered the vaccination will be those born between 1 September 1990 and 31 August 1991.

A spokeswoman for the DoH said that the vaccination programme for the 17- to 18-year-olds could be done in GP surgeries or in colleges and that it would be up to PCTs to decide how best to deliver the programme.

But Dr Angela Raffle, public health lead for cervical screening at Bristol PCT, said: 'This has been rushed and will put impossible pressure on GPs and nurses.'

The move comes after the DoH was heavily criticised for saving £18.6 million a year by choosing the cheaper HPV vaccine Cervarix. Unlike its rival Gardasil, Cervarix offers no protection against the virus that causes genital warts.

Public health minister Dawn Primarolo, said: 'By choosing this vaccine we have been able to make savings, which will mean we can extend the programme to 17- and 18-year-olds. This could save an additional 400 lives.'

But Dr Raffle believes the extended programme is in response to criticism that the DoH chose Cervarix over Gardasil to save money.

Fiona Smith, RCN adviser in children and young people's nursing, welcomed the HPV vaccination programme. However, she questioned whether the DoH had allocated sufficient resources to roll out the programme and if there were enough school nurses to deliver it.

Education and training is required for the school nurse work force on HPV, added Ms Smith.

HPV vaccination

- A total of 300,000 17- and 18-year-olds added to vaccination campaign.

- Vaccines to be provided in schools and GP practices.

- Catch-up programme to start in September.

- PCTs will decide how to deliver the programme locally.

- The government's chosen vaccine, Cervarix, will cost £18.6 million less than its rival Gardasil, which also protects against genital warts.

 

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Nursing Professional Issues

Green practice for nurses

With spiralling energy costs, it is important to adopt policies that can save money as well as the e... Read More

Diabetes Year of Care

A radical programme promises to transform care for people with diabetes, writes Fiona Barr. Read More

Improving health in schools Improving health in schools

Health and education are working together to improve young people's health and wellbeing, writes Sar... Read More

Show all articles

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs

 

Job of the Week